Genetically proxied inhibition of L-2-hydroxyglutarate dehydrogenase reduces the risk of coronary artery disease: A Mendelian randomization study https://www.medrxiv.org/content/10.1101/2023.01.15.23284550
Genetically proxied inhibition of L-2-hydroxyglutarate dehydrogenase reduces the risk of coronary artery disease: A Mendelian randomization study https://www.medrxiv.org/content/10.1101/2023.01.15.23284550